Breast cancer is one of the most common types of cancer among women globally. It is
caused by mutations in the estrogen/progesterone receptors and conventional treatment …

Over the last few years, great emphasis has been given to develop ruthenium complexes to
act as target specified chemotherapeutic agents. Indeed, there are few reviews available …

Cancer, a widespread and lethal disease, necessitates precise therapeutic interventions to
mitigate its devastating impact. While conventional chemotherapy remains a cornerstone of …

Countless expectations converge in the multidisciplinary endeavour for the search and
development of effective and safe drugs in fighting cancer. Although they still embody a …

Lung cancer is one of the most common malignancies with the highest mortality rate and the
second-highest incidence rate after breast cancer, posing a serious threat to human health …

Simple Summary In this manuscript, we review the progress in knowledge made over the
last decade, which, thanks to the commitment of many academics and researchers, has …

This review focuses on studies of coordination and organometallic compounds as potential
chemotherapeutics against triple negative breast cancer (TNBC) which has one of the …

Carbon nanotubes (CNTs) are allotropes of carbon, composed of carbon atoms forming a
tube-like structure. Their high surface area, chemical stability, and rich electronic …

The great advances in the studies on metal complexes for the treatment of different cancer
forms, starting from the pioneering works on platinum derivatives, have fostered an …

First studies on thrombin-inhibiting DNA aptamers were reported in 1992, and since then a
large number of anticoagulant aptamers has been discovered. TBA–also named HD1, a 15 …